Unlock instant, AI-driven research and patent intelligence for your innovation.

Novel mutant EN-46 of human epidermal growth factor

An epidermal growth factor, EN-46 technology, applied in the fields of epidermal growth factor, growth factor/inducing factor, microorganism-based method, etc., can solve the problems of low final product yield, difficult quality control, mismatch, etc. Industrial production, easy extraction, separation and purification, and enhanced permeability

Active Publication Date: 2012-09-05
SHENZHEN WATSIN GENETECH
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Mismatches often occur in the expression product during the denaturation and renaturation process, the final yield of the product is extremely low, and the quality is difficult to control
This defect has become the biggest technical obstacle in the industrialization of recombinant protein in E. coli expression system

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel mutant EN-46 of human epidermal growth factor
  • Novel mutant EN-46 of human epidermal growth factor
  • Novel mutant EN-46 of human epidermal growth factor

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0095] Embodiment 1 adopts PCR random mutation technique to obtain mutant EN-46 nucleic acid molecule

[0096] Entrust Invitrogen to synthesize PCR primers (primer1 and primer2):

[0097] Primer1: 5'-CAT CAT ATG AAA AAG ACA GCT ATC-3'

[0098] Nd

[0099] Primer2: 5'-CAT CTG CAG TTA TTA ACG CAG TCC CAC-3’

[0100] PstI

[0101] Add to the 50μl PCR reaction system:

[0102] h 2 O 37μl

[0103]10XPCR buffer 5μl

[0104] 4dNTP (200μM each) 4μl

[0105] Primer1 (0.25μM) 1μl

[0106] Primer2 (0.25μM) 1μl

[0107] Template DNA (ompA-EGF) 1μl

[0108] Taq enzyme 1μl

[0109] PCR reaction:

[0110] Preheat at 94°C for 5 minutes, according to the program: 94°C, 30 seconds-50°C, 30 seconds-72°C, 30 seconds, 25 cycles of reaction.

[0111] PCR reaction

[0112]

Embodiment 2

[0113] Construction of embodiment 2 mutant EN-46 expression vector plasmid

[0114] The NdeI / PstI fragment of the PCR product was connected to the Y2K0422 (NdeI / PstI) expression vector. The obtained mutant gene EN-46 was placed between the strong promoter T7 and the terminator rrnBT1T2. Y2K0422 is a high-efficiency expression vector plasmid constructed and preserved by our company. This expression vector plasmid has a high copy number, and can inhibit the expression of non-target proteins after IPTG induction to obtain the highest expression of target proteins. The expression vector plasmid can also be replaced by a commercially available expression vector of the same type that has the same or equivalent characteristics as the Y2K0422 expression vector plasmid.

[0115] PCR product (NdeI / PstI) double restriction fragment

[0116]

[0117] Expression framework of mutant EN-46

[0118] in:

[0119] T7pro is T7 promoter

[0120] ompA is the leader peptide of Escherichia ...

Embodiment 3

[0124] Embodiment 3 expression vector plasmid transforms host bacterium, the cultivation and induced expression of host bacterium, and the engineering strain of screening high-efficiency expression

[0125] 1. Expression vector plasmid transformation host bacteria

[0126] The above constructed plasmid was transformed into Escherichia coli E. coli JM109 (DE3) by conventional methods, and the transformant containing the above expression framework was used to screen colonies with high expression of EN-46.

[0127] 2. Cultivation and induced expression of engineering bacteria and identification of expression product cells

[0128] Several transformant colonies were selected for expression experiments in test tubes. Ordinary LB medium for expression test (g / 1): peptone 10-15; yeast extract 5-15; NaCl 5-10; NaCl 2 HPO 4 0-10; ampicillin 0.1-0.2, initial pH 7.0.

[0129] Inoculate the test tube and incubate at 37°C to OD 600 When it reaches 3.0-4.0, add 100mM IPTG to induce ex...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of bioengineering and provides a novel mutant EN-46 of a human epidermal growth factor, in particular to a mutant EN-46 and a nucleic acid sequence of the mutant EN-46 as well as a vector containing the nucleic acid sequence and engineering bacteria containing the vector. The invention also provides a method for preparing C-end frameshift mutant of thehuman epidermal growth factor, in particular to a method for preparing the mutant EN-46, a composition containing the mutant and application of the composition in preparing medicines, health productsor cosmetics. The mutant can achieve complete soluble expression in escherichia coli, the permeability of a cell membrane is enhanced, and expression products are completely secreted in an extracellular culture medium and entirely have the biologicalactivity of the human epidermal growth factor.

Description

technical field [0001] The invention relates to a human epidermal growth factor, in particular to a mutant of the human epidermal growth factor, its preparation method and application. Background technique [0002] From 1960 to 1963, American biologist Professor Cohen and others discovered a polypeptide in the submandibular gland of mice, which has a wide range of cell proliferation-promoting effects, and named it epidermal growth factor (EGF for short). Shortly thereafter, scientists discovered a similar active substance, known as human epidermal growth factor (hEGF), in human urine. Later studies further confirmed that epidermal growth factor widely exists in humans and mammals. It is a small molecule polypeptide with a molecular weight of 6222 composed of 53 amino acids and an isoelectric point of 4.6. Mouse and human epidermal growth factors have a high degree of homology. Epidermal growth factor has a wide range of biological activities, and plays an important role in...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K14/485C07K1/20C12R1/19
Inventor 涂桂洪王晓晶唐洁成何颖芝
Owner SHENZHEN WATSIN GENETECH